XML 65 R58.htm IDEA: XBRL DOCUMENT v3.25.1
CAPITAL STOCK (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Feb. 29, 2024
Mar. 31, 2023
Oct. 31, 2020
Dec. 31, 2024
Sep. 30, 2023
Dec. 31, 2024
Dec. 31, 2023
Mar. 31, 2023
Sep. 30, 2024
Mar. 31, 2024
Oct. 31, 2017
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Common stock, shares authorized       200,000,000   200,000,000       200,000,000  
Common stock, par value       $ 0.001   $ 0.001       $ 0.001  
Stock options to purchase, granted               400,000      
Options shall vest         300,000     100,000      
Shares forfeited         25,000            
Expenses related to options       $ 27,330   $ 101,953 $ 380,045        
Unrecognized compensation expense related to unvested employee stock option       70,710   $ 70,710          
Weighted average period           1 year 6 months          
Stock based award, unrecognized compensation expense       $ 1,222,234   $ 1,222,234          
Weighted average remaining life (years)           1 year 10 months 28 days          
2017 Equity Incentive Plan [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Number of shares of common stock approved for issuance (in shares)                 9,000,000   485,000
Shares available to issue       2,400,148   2,400,148          
Number of additional shares authorized (in shares) 3,000,000 1,000,000 4,515,000                
Warrant [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants outstanding       1,721,256   1,721,256          
Warrant [Member] | Until December 2026 [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Issuance of warrants, description           Each warrant provides the holder the right to purchase up to one share of our Common Stock at a predetermined exercise price. The outstanding warrants consist of (1) warrants to purchase 100,000 shares of Common Stock at an exercise price of $0.01 per share until December 2026; (2) warrants to purchase 911 shares of Common Stock at an exercise price of $1.65 per share until April 2025; (3) warrants to purchase 1,234,034 shares of our Common Stock at an exercise price of $2.00 per share consisting of 1% of the warrants that expired on August 2024, and 99% until February 2026; and (4) warrants to purchase 386,311 shares of Common Stock at an exercise price of $2.63 until November 2025          
Warrant One [Member] | Until April 2025 [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants issued to purchase common stock       911   911          
Warrants exercise price       $ 1.65   $ 1.65          
Warrant Two [Member] | Expired August 2024 [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants issued to purchase common stock       1,234,034   1,234,034          
Warrants exercise price       $ 2   $ 2          
Warrant Three [Member] | Until November 2025 [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants issued to purchase common stock       386,311   386,311          
Warrants exercise price       $ 2.63   $ 2.63          
Warrant Five [Member] | Until December 2026 [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants issued to purchase common stock       100,000   100,000          
Warrants exercise price       $ 0.01   $ 0.01